Article Details

FDA Grants Orphan Drug Designation to NT-I7 in Advanced Pancreatic Cancer

Retrieved on: 2024-02-05 19:10:47

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Orphan Drug Designation to NT-I7 in Advanced Pancreatic Cancer. View article details on hiswai:

Excerpt

Treatment with NT-I7 may boost the immune system and enhance antitumor activity in patients with pancreatic cancer and other solid tumors.

Article found on: www.cancernetwork.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo